Diagnosis, staging and treatment of patients with prostate cancer: national clinical guideline no.8

Hdl Handle:
http://hdl.handle.net/10147/577266
Title:
Diagnosis, staging and treatment of patients with prostate cancer: national clinical guideline no.8
Authors:
Department of Health (DoH); National Clinical Effectiveness Committee (NCEC)
Citation:
Department of Health,
Publisher:
Department of Health (DoH)
Issue Date:
Jun-2015
URI:
http://hdl.handle.net/10147/577266
Item Type:
Guideline
Language:
en
Description:
Cancer is a major healthcare challenge. Each year in Ireland, approximately 19,000 people are diagnosed with malignant cancer. Cancer is the second leading cause of death in Ireland after diseases of the circulatory system. Deaths from cancer averaged about 8,800 deaths per year during 2010-2012, representing about 30% of all deaths in that period (NCRI, 2014a). Cancer incidence data from the National Cancer Registry Ireland (NCRI) and population projections from the Central Statistics Office (CSO) have been combined by the NCRI to estimate the number of new cancer cases expected in five year bands from 2015 to 2040. The total number of new invasive cancer cases (including non-melanoma skin cancer) is projected to increase by 84% for females and 107% for males between 2010 and 2040, based only on changes in population size and age distribution (demography). If trends in incidence since 1994 are also taken into account, the number of cases is expected to increase by between 86% and 125% for females (depending on the method of projection used) and by between 126% and 133% for males (NCRI, 2014b). Prostate cancer is the most common cancer in men (excluding non-melanoma skin cancer). The annual average incidence for prostate cancer in Ireland between 2010 and 2012 was 3,384 cases per annum, accounting for a little over 30% of all newly diagnosed cases of cancer in men (NCRI, 2014a). Prostate cancer incidence in Ireland is currently one of the highest in Europe and estimated incidence rates in Ireland for 2012 are approximately 1.5 times higher than in the UK or the EU overall (NCRI, 2014c). The chances of developing prostate cancer increase as you get older. Most cases develop in men aged 70 or older. For reasons that are not understood, prostate cancer is more common in men of Afro-Caribbean or African descent, and less common in men of Asian descent. The causes of prostate cancer are largely unknown (HSE, 2014)
Keywords:
HEALTH SERVICES AND THEIR MANAGEMENT; PROSTRATE CANCER

Full metadata record

DC FieldValue Language
dc.contributor.authorDepartment of Health (DoH)en
dc.contributor.authorNational Clinical Effectiveness Committee (NCEC)en
dc.date.accessioned2015-09-14T11:14:39Zen
dc.date.available2015-09-14T11:14:39Zen
dc.date.issued2015-06en
dc.identifier.citationDepartment of Health,en
dc.identifier.urihttp://hdl.handle.net/10147/577266en
dc.descriptionCancer is a major healthcare challenge. Each year in Ireland, approximately 19,000 people are diagnosed with malignant cancer. Cancer is the second leading cause of death in Ireland after diseases of the circulatory system. Deaths from cancer averaged about 8,800 deaths per year during 2010-2012, representing about 30% of all deaths in that period (NCRI, 2014a). Cancer incidence data from the National Cancer Registry Ireland (NCRI) and population projections from the Central Statistics Office (CSO) have been combined by the NCRI to estimate the number of new cancer cases expected in five year bands from 2015 to 2040. The total number of new invasive cancer cases (including non-melanoma skin cancer) is projected to increase by 84% for females and 107% for males between 2010 and 2040, based only on changes in population size and age distribution (demography). If trends in incidence since 1994 are also taken into account, the number of cases is expected to increase by between 86% and 125% for females (depending on the method of projection used) and by between 126% and 133% for males (NCRI, 2014b). Prostate cancer is the most common cancer in men (excluding non-melanoma skin cancer). The annual average incidence for prostate cancer in Ireland between 2010 and 2012 was 3,384 cases per annum, accounting for a little over 30% of all newly diagnosed cases of cancer in men (NCRI, 2014a). Prostate cancer incidence in Ireland is currently one of the highest in Europe and estimated incidence rates in Ireland for 2012 are approximately 1.5 times higher than in the UK or the EU overall (NCRI, 2014c). The chances of developing prostate cancer increase as you get older. Most cases develop in men aged 70 or older. For reasons that are not understood, prostate cancer is more common in men of Afro-Caribbean or African descent, and less common in men of Asian descent. The causes of prostate cancer are largely unknown (HSE, 2014)en
dc.language.isoenen
dc.publisherDepartment of Health (DoH)en
dc.subjectHEALTH SERVICES AND THEIR MANAGEMENTen
dc.subjectPROSTRATE CANCERen
dc.titleDiagnosis, staging and treatment of patients with prostate cancer: national clinical guideline no.8en
dc.typeGuidelineen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.